Biotech Asks 1st Circ. To Undo Red Cross Antitrust Immunity
A biotech firm asked the First Circuit on Friday to undo a district court decision granting the American Red Cross immunity from antitrust allegations, arguing the blood donation giant was wrongly...To view the full article, register now.
Already a subscriber? Click here to view full article